Total Debt Summary of Bioqual, Inc.

Bioqual, Inc.'s latest annual total debt in 2023 was 3.58 Million USD , down -76.35% from previous year.
Bioqual, Inc.'s latest quarterly total debt in 2024 Q1 was 3.63 Million USD , up 1.46% from previous quarter.
Bioqual, Inc. reported annual total debt of 15.16 Million USD in 2022, down -19.01% from previous year.
Bioqual, Inc. reported annual total debt of 18.72 Million USD in 2021, up 28.09% from previous year.
Bioqual, Inc. reported quarterly total debt of 16.75 Million USD for 2023 Q2, down -5.38% from previous quarter.
Bioqual, Inc. reported quarterly total debt of 3.58 Million USD for 2023 Q4, down -77.3% from previous quarter.

Annual Total Debt Chart of Bioqual, Inc. (2023 - 1995)

Historical Annual Total Debt of Bioqual, Inc. (2023 - 1995)

Year	Total Debt	Total Debt Growth
2023	3.58 Million USD	-76.35%
2022	15.16 Million USD	-19.01%
2021	18.72 Million USD	28.09%
2020	14.61 Million USD	-9.46%
2019	16.14 Million USD	0.0%
2018	- USD	-100.0%
2017	250.11 Thousand USD	-55.91%
2016	567.32 Thousand USD	-34.79%
2015	870.05 Thousand USD	-24.92%
2014	1.15 Million USD	-19.22%
2013	1.43 Million USD	0.0%
2012	- USD	0.0%
2010	- USD	0.0%
2009	- USD	0.0%
2006	- USD	0.0%
2005	- USD	0.0%
2004	- USD	0.0%
2003	- USD	0.0%
2002	- USD	0.0%
2000	384.87 Thousand USD	-61.57%
1999	1 Million USD	151.88%
1998	397.58 Thousand USD	-16.31%
1997	475.09 Thousand USD	-42.38%
1996	824.46 Thousand USD	104.96%
1995	402.26 Thousand USD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	3.63 Million USD	1.46%
2023 Q2	16.75 Million USD	-5.38%
2023 Q4	3.58 Million USD	-77.3%
2023 Q1	17.71 Million USD	-4.83%
2023 Q3	15.8 Million USD	-5.7%
2022 Q4	18.6 Million USD	-4.56%
2022 Q3	19.49 Million USD	-4.3%
2022 FY	18.6 Million USD	-0.62%
2022 Q2	20.37 Million USD	-4.06%
2022 Q1	21.23 Million USD	13.41%
2021 Q3	19.56 Million USD	-3.68%
2021 Q4	18.72 Million USD	-4.31%
2021 FY	18.72 Million USD	28.09%
2021 Q1	13.81 Million USD	-5.52%
2021 Q2	20.31 Million USD	47.11%
2020 Q1	13.7 Million USD	3.27%
2020 FY	14.61 Million USD	-9.46%
2020 Q2	12.88 Million USD	-5.99%
2020 Q3	12.04 Million USD	-6.53%
2020 Q4	14.61 Million USD	21.39%
2019 Q3	13.36 Million USD	-5.65%
2019 Q1	14.48 Million USD	0.0%
2019 Q4	13.27 Million USD	-0.67%
2019 FY	16.14 Million USD	0.0%
2019 Q2	14.15 Million USD	-2.22%
2018 Q2	85.86 Thousand USD	-49.03%
2018 FY	- USD	-100.0%
2018 Q4	- USD	0.0%
2018 Q3	- USD	-100.0%
2018 Q1	168.48 Thousand USD	-32.64%
2017 Q2	410.6 Thousand USD	-16.11%
2017 Q4	250.11 Thousand USD	-24.39%
2017 FY	250.11 Thousand USD	-55.91%
2017 Q3	330.78 Thousand USD	-19.44%
2017 Q1	489.45 Thousand USD	-13.73%
2016 Q2	- USD	-100.0%
2016 FY	567.32 Thousand USD	-34.79%
2016 Q1	795.77 Thousand USD	-8.54%
2016 Q4	567.32 Thousand USD	0.0%
2015 Q4	870.05 Thousand USD	-7.78%
2015 Q3	943.46 Thousand USD	-7.15%
2015 Q2	1.01 Million USD	-6.6%
2015 Q1	1.08 Million USD	-6.11%
2015 FY	870.05 Thousand USD	-24.92%
2014 Q3	1.22 Million USD	-5.35%
2014 FY	1.15 Million USD	-19.22%
2014 Q1	1.36 Million USD	-4.71%
2014 Q4	1.15 Million USD	-5.7%
2014 Q2	1.29 Million USD	-5.02%
2013 Q2	- USD	0.0%
2013 Q3	1.5 Million USD	0.0%
2013 Q4	1.43 Million USD	-4.36%
2013 FY	1.43 Million USD	0.0%
2013 Q1	- USD	0.0%
2012 FY	- USD	0.0%
2012 Q4	- USD	0.0%
2012 Q3	- USD	0.0%
2012 Q2	- USD	0.0%
2011 Q1	- USD	0.0%
2010 FY	- USD	0.0%
2010 Q3	- USD	0.0%
2010 Q4	- USD	0.0%
2010 Q2	- USD	0.0%
2009 Q4	- USD	0.0%
2009 FY	- USD	0.0%
2006 Q1	316.36 Thousand USD	0.0%
2006 Q3	- USD	0.0%
2006 FY	- USD	0.0%
2006 Q4	- USD	0.0%
2006 Q2	- USD	-100.0%
2005 FY	- USD	0.0%
2005 Q4	- USD	0.0%
2004 FY	- USD	0.0%
2003 FY	- USD	0.0%
2002 FY	- USD	0.0%
2001 Q2	501.66 Thousand USD	16.02%
2001 Q3	373.81 Thousand USD	-25.49%
2001 Q1	432.39 Thousand USD	12.34%
2000 Q1	637.83 Thousand USD	-36.31%
2000 Q4	384.87 Thousand USD	-48.08%
2000 Q2	526.66 Thousand USD	-17.43%
2000 FY	384.87 Thousand USD	-61.57%
2000 Q3	741.35 Thousand USD	40.77%
1999 Q2	917.11 Thousand USD	0.0%
1999 FY	1 Million USD	151.88%
1999 Q4	1 Million USD	11.78%
1999 Q3	895.88 Thousand USD	-2.32%
1998 FY	397.58 Thousand USD	-16.31%
1997 FY	475.09 Thousand USD	-42.38%
1996 FY	824.46 Thousand USD	104.96%
1995 FY	402.26 Thousand USD	0.0%

Peer Total Debt Comparison of Bioqual, Inc.

Name	Total Debt	Total Debt Difference
American Bio Medica Corporation	2.24 Million USD	-60.133%
Arrayit Corporation	1.07 Million USD	-232.693%
Atlantic International Corp.	2.93 Million USD	-22.402%
Biocept, Inc.	12.1 Million USD	70.378%
CardioGenics Holdings Inc	72.61 Thousand USD	-4839.798%
DermTech, Inc.	54.39 Million USD	93.406%
Global WholeHealth Partners Corporation	- USD	-Infinity%
Hangzhou Tigermed Consulting Co., Ltd.	471.86 Million USD	99.24%
HTG Molecular Diagnostics, Inc.	4.83 Million USD	25.796%
iMD Companies, Inc.	1.12 Million USD	-220.224%
IDenta Corp.	789.14 Thousand USD	-354.54%
Interpace Biosciences, Inc.	11.19 Million USD	67.95%
Integrative Health Technologies, Inc.	- USD	-Infinity%
InVitro International	43.84 Thousand USD	-8081.058%
Lumos Diagnostics Holdings Limited	8.04 Million USD	55.413%
Many Bright Ideas Technologies Inc.	- USD	-Infinity%
Medical Imaging Corp.	3.82 Million USD	6.244%
NovelStem International Corp.	3.57 Million USD	-0.347%
Optigenex Inc.	8.94 Million USD	59.88%
PharmChem, Inc.	77.35 Thousand USD	-4537.163%
Proteome Sciences plc	17.15 Million USD	79.089%
Response Genetics, Inc	6.37 Million USD	43.716%
Rennova Health, Inc.	15.32 Million USD	76.601%
RushNet, Inc.	4.82 Million USD	25.629%
ScreenPro Security Inc.	207.03 Thousand USD	-1632.558%
Stella Diagnostics Inc.	6.2 Million USD	42.152%
StageZero Life Sciences Ltd.	1.8 Million USD	-99.268%
Todos Medical Ltd.	38.34 Million USD	90.646%

Global Stocks Search

Bioqual, Inc. (BIOQ)

Total Debt Summary of Bioqual, Inc.

Annual Total Debt Chart of Bioqual, Inc. (2023 - 1995)

Historical Annual Total Debt of Bioqual, Inc. (2023 - 1995)

Peer Total Debt Comparison of Bioqual, Inc.